Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEconomic Burden of Venous Thromboembolism in Hospitalized Patients
Pharmacotherapy, 08/05/09
Dobesh PP – Even though the strong evidence supporting venous thromboembolism prophylaxis spans several decades, a number of large American and global registries have documented very poor use of appropriate venous thromboprophylaxis. Because of increasing regulatory requirements, hospitals nationwide are developing necessary documentation of appropriate venous thromboembolism prophylaxis programs for both surgical and medical patients. Hospitals and clinicians must have a firm understanding of not only the clinical impact but also the economic impact of failing to use appropriate prophylaxis and of the cost–effectiveness of different venous thromboprophylaxis methods
Related Articles
Prevention of Venous Thromboembolism in Thoracic and Cardiovascular Surgery
Asian Cardiovascular and Thoracic Annals, 11/20/09
Relevance Score: 88%%
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study
Blood, 12/01/09
Relevance Score: 87%%
Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials
Circulation, 11/04/09
Relevance Score: 87%%
Vena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients: A prospective, observational cohort study
Chest, 11/03/09
Relevance Score: 85%%
Deciphering the molecular basis of venous thromboembolism: where are we and where should we go?
British Journal of Haematology, 11/20/09
Relevance Score: 84%%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Economic Evaluation of Pharmacotherapy of Migraine Pain: A Review of the Literature
Journal Of Pain & Palliative Care Pharmacotherapy, 12/02/09
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Infection Control and Hospital Epidemiology, 12/02/09
Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences
PharmacoEconomics, 11/30/09
Sponsor
Article Search
Sponsor